Sowell Financial Services LLC Global Blood Therapeutics, Inc. Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$32.46 - $43.42 $22,786 - $30,480	-702 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$38.94 - $50.85 $389 - $508	-10 Reduced 1.4%	702 $27,000
Q4 2020 Jan 13, 2021	BUY	$37.65 - $63.77 $7,530 - $12,754	200 Added 39.06%	712 $31,000
Q3 2020 Nov 12, 2020	SELL	$52.76 - $74.49 $2,638 - $3,724	-50 Reduced 8.9%	512 $28,000
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $4,970 - $8,345	102 Added 22.17%	562 $35,000
Q1 2020 May 12, 2020	SELL	$41.72 - $87.2 $13,767 - $28,776	-330 Reduced 41.77%	460 $24,000
Q4 2019 Feb 07, 2020	BUY	$45.7 - $81.86 $36,103 - $64,669	790 New	790 $62,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.